Athens | Ghent | Pecs | Stockholm | Vienna | Zaragoza | Total | |
---|---|---|---|---|---|---|---|
Included participants with a valid ASQ | |||||||
Participants (n) | 33 | 290 | 208 | 259 | 44 | 306 | 1140 |
Gender (% boys) | 33.3 | 41.7 | 53.4 | 35.9 | 18.2 | 48.4 | 43.2 |
Age (mean ± SD)) | 13.2 ± 0.5 | 14.8 ± 1.2 | 14.4 ± 1.2 | 14.9 ± 1.2 | 15.9 ± 0.6 | 14.7 ± 1.1 | 14.7 ± 1.2 |
SES (mean ± SD) | 2.9 ± 1.8 | 5.5 ± 1.5 | 3.9 ± 1.7 | 5.4 ± 1.4 | 5.3 ± 1.3 | 4.5 ± 1.5 | 4.8 ± 1.7 |
Pubertal status (%) | |||||||
Pre-pubertal (stage I) | 6.1 | 0.3 | 0.0 | 0.4 | 0.0 | 0.0 | 0.4 |
Beginning pubertal (stage II) | 27.3 | 3.8 | 1.4 | 8.9 | 0.0 | 1.6 | 4.5 |
Mid-pubertal (stage III) | 57.6 | 12.1 | 19.2 | 28.2 | 0.0 | 5.9 | 16.2 |
Advanced pubertal (stage IV) | 6.1 | 33.1 | 54.3 | 42.5 | 97.7 | 12.4 | 35.3 |
Post-pubertal (stage V) | 3.0 | 47.6 | 24.0 | 12.4 | 0.0 | 75.8 | 39.7 |
Missing | 0.0 | 3.1 | 1.0 | 7.7 | 2.3 | 4.2 | 3.9 |
Included participants with a valid ASQ and cortisol samples | |||||||
Participants (n) | 27 | 39 | 30 | 34 | 20 | 50 | 200 |
Gender (% boys) | 29.6 | 56.4 | 43.3 | 44.1 | 20.0 | 46.0 | 42.5 |
Age (mean ± SD)) | 13.2 ± 0.4 | 15.5 ± 1.0 | 13.5 ± 0.5 | 13.5 ± 0.4 | 16.1 ± 0.4 | 14.3 ± 0.6 | 14.3 ± 1.2 |
SES (mean ± SD) | 2.6 ± 1.8 | 5.9 ± 1.3 | 3.3 ± 1.3 | 5.5 ± 1.3 | 5.5 ± 1.4 | 5.3 ± 1.4 | 4.8 ± 1.8 |
Pubertal status (%) | |||||||
Pre-pubertal (stage I) | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
Beginning pubertal (stage II) | 29.6 | 0.0 | 3.3 | 23.5 | 0.0 | 0.0 | 8.5 |
Mid-pubertal (stage III) | 59.3 | 7.7 | 23.3 | 55.9 | 0.0 | 8.0 | 24.5 |
Advanced pubertal (stage IV) | 7.4 | 53.8 | 73.3 | 14.7 | 95.0 | 20.0 | 39.5 |
Post-pubertal (stage V) | 0.0 | 35.9 | 0.0 | 2.9 | 0.0 | 72.0 | 25.5 |
Missing | 0.0 | 2.6 | 0.0 | 2.9 | 5.0 | 0.0 | 1.5 |